title: Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option.
authors.affiliation: Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, 68198, USA. zyuan@kumc.edu.
authors.forename: Ziyan Yuan
authors.initials: ZY
authors.lastname: Pessetto
authors.affiliation: Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
authors.forename: Ying
authors.initials: Y
authors.lastname: Yan
authors.affiliation: Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
authors.forename: Tadayoshi
authors.initials: T
authors.lastname: Bessho
authors.affiliation: Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, 68198, USA. anatarajan@unmc.edu.|Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA. anatarajan@unmc.edu.|Department of Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, 68198, USA. anatarajan@unmc.edu.
authors.forename: Amarnath
authors.initials: A
authors.lastname: Natarajan